Frequently Asked Questions

Get answers to common questions about Liraglutide Program.

The Liraglutide Program combines daily GLP-1 therapy with medical oversight, individualized dosing, lab monitoring, and lifestyle support. Appetite control, metabolic improvements, and steady weight loss are emphasized, while adjustments and counseling encourage sustainable habits and long-term maintenance.

We require baseline screening, periodic labs, and clinician-supervised titration to ensure safety. Telehealth access allows timely side-effect management, and emergency protocols are in place. Providers review medications and medical history to reduce interaction risks.

Ideal candidates are adults with overweight or obesity seeking medically supervised weight optimization. Candidates should have BMI criteria, be committed to follow-up, and undergo medical evaluation; certain conditions like pregnancy or specific contraindications may exclude some individuals.

Initial telehealth visits typically occur weekly during dose titration, then transition to biweekly or monthly check-ins based on progress. Clinicians are available for as-needed consultations, ensuring adjustments and support between scheduled appointments.

Insurance coverage varies; many plans do not cover weight-loss medications or telehealth packages. We provide billing guidance, documentation, and can assist with prior authorization when applicable. Clients often pay out-of-pocket, and medication costs depend on pharmacy and insurance formularies.

Common side effects include nausea, vomiting, constipation, or diarrhea, usually mild and transient. Clinicians adjust dosing and provide strategies to manage symptoms. Rare but serious risks exist; prompt evaluation is required for severe abdominal pain, persistent vomiting, or allergic reactions.